ETH-Department of Biosystems Science and Engineering (D-BSSE)

D-BSSE research is driven by open scientific questions and unmet societal needs in biotechnology and life sciences. The mission of D-BSSE is the understanding, rational design and programming of complex biological systems from the nanoscale up to whole organisms. Today, we are hosting the Personalised Health Conference with an excellent lineup of keynote speakers: Adrian Egli, Director of the UZH-Institute of Medical Microbiology, Emma Slack, ETH-Professor for Mucosal Immunology, and Jacques Fellay, EPFL-Professor of Genomics and Precision Medicine. Scientists from the D-BSSE and the EU-funded network Machine Learning Frontiers in Precision Medicine also share their latest findings and perspectives on translational research and personalised health. At D-BSSE, experimental and computational biologists and engineers work together on the understanding, rational design and programming of complex biological systems from the nanoscale up to whole organisms. At the Department of Biosystems Science and Engineering (D-BSSE ), experimental and computational biologists and engineers work together in an interdisciplinary team in order to conduct comprehensive analysis of complex processes in cells and organisms. Education, research and entrepreneurship at D-BSSE in Basel strengthen collaboration in life sciences internationally and in the Zurich and Basel areas. Developing novel antibacterial products for life-threatening infections, BioVersys announced on 5 March that in partnership with the pharma and biotech company GSK they have successfully completed the Innovative Medicines Initiative (IMI2) funded programme and reached a key milestone of delivering a Phase 2-ready tuberculosis clinical candidate.